Search Results - Hugo Boonen

Evolution of patient demographics, baseline clinical characteristics and outcomes in Phase 3 trials of biologics (TNFi, IL12/23i, IL17i, IL23i), PDE4i and TYK2i for psoriasis by Sara Peeters, Kurt De Vlam, Hugo Boonen, Canan Güvenç, Tom Hillary

Connect to this object online.

Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study by Pierre-Dominique Ghislain, MD, Valérie Failla, MD, Jo Lambert, MD, PhD, Rani Soenen, MD, Lynda Grine, MD, Julio Tannous, MD, Françoise Guiot, MD, Fabienne Willaert, MD, Hugues Fierens, MD, Mark Vandaele, MD, Hugo Boonen, MD, Julie Saerens, MD, Véronique Meuleman, MD, Annelies Stockman, MD, Arno Belpaire, MD, Sandra Swimberghe, MD, Linda Temmerman, MD, Sam Dekeyser, MD, Jean-Michel Lambert, MD, Virginie de Schaetzen, MD, Michel de la Brassinne, MD, Farida Benhadou, MD, PhD

Connect to this object online.